Aug 22, 2017
“It’s really like a heat-seeking missile toward tumors,” Yale physician-scientist and Cybrexa’s chief scientific adviser, Dr. Ranjit Bindra, tells the Hartford Courant. “I know it sounds over the top but we’re really re-writing the rules of what makes a drug good and what drugs are possible to deliver to humans.”
Dr. Ranjit Bindra, co-founder of Cybrexa, and Per Hellsund, President and CEO, sat down with the Hartford Courant to discuss the venture’s origins and technology. Read the full article (and watch the video) HERE.
